Observations placeholder
Tagamet
Identifier
015717
Type of Spiritual Experience
Number of hallucinations: 59
Background
A description of the experience
Cimetidine INN is a histamine H2-receptor antagonist that inhibits stomach acid production. It is largely used in the treatment of heartburn and peptic ulcers. It has been marketed under the trade name Tagamet (sometimes Tagamet HB or Tagamet HB200). Cimetidine was approved in the UK in 1976, and was approved in the US by the Food and Drug Administration for prescriptions starting January 1, 1979.
On Apr, 1, 2015: 5,664 people reported to have side effects when taking Tagamet. Among them, 59 people (1.04%) have Hallucination.
Time on Tagamet when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Tagamet :
| Female | Male | |
| Hallucination | 59.32% | 40.68% |
Age of people who have Hallucination when taking Tagamet :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 15.69% | 1.96% | 19.61% | 7.84% | 54.90% |
On Jan, 16, 2017 6,413 people reported to have side effects when taking Tagamet.
Among them, 248 people (3.87%) have Death
Time on Tagamet when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 83.33% | 0.00% | 0.00% | 0.00% | 16.67% | 0.00% | 0.00% |